Michael Sofia
Personal wealth note: Equibles reports source-backed professional activity and disclosed compensation; it does not estimate personal net worth.
About Michael Sofia
The proxy statement of Arbutus Biopharma Corp reports total compensation of $1,820,054 for Michael Sofia in fiscal 2024, including a base salary of $512,000. Disclosed compensation is on record for 6 fiscal years.
Summary generated from SEC filings and earnings-call records held by Equibles.
Affiliation history
Recorded current and former roles; source labels appear when available.
-
Arbutus Biopharma Corp (ABUS)
Proxy statement
Start not stated–2024-12-31
Company network
Recorded roles and call appearances connecting this person to public companies.
Executive compensation
Compensation components disclosed in company proxy statements. Amounts are nominal USD; total is the company-reported figure.
| Fiscal year | Company | Role | Salary | Total |
|---|---|---|---|---|
| 2024 | Arbutus Biopharma Corp (ABUS) | Former Chief Scientific Officer | $512,000 | $1,820,054 |
| 2023 | Arbutus Biopharma Corp (ABUS) | Former Chief Scientific Officer | $492,000 | $1,614,688 |
| 2022 | Arbutus Biopharma Corp (ABUS) | Chief Scientific Officer | $468,000 | $1,248,210 |
| 2021 | Arbutus Biopharma Corp (ABUS) | Chief Scientific Officer | $452,100 | $1,609,160 |
| 2020 | Arbutus Biopharma Corp (ABUS) | Chief Scientific Officer | $439,000 | $1,243,203 |
| 2019 | Arbutus Biopharma Corp (ABUS) | Chief Scientific Officer | $422,300 | $1,051,388 |
Recent activity
No call appearances or filed executive changes recorded yet.